CClinicalTrials.gg
RecruitingNCT05888480Updated Feb 28, 2024

A Culturally Specific End-of-life Communication Skills Training

An interventional study of The end-of-life communication skills training and Routine training activity in End-Of-Life, sponsored by The Hong Kong Polytechnic University. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-28.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
148
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate the effectiveness of culturally specific end-of-life communication skills training (CST) among Chinese oncology nurses.

The main question it aims to answer is: What is the effectiveness of culturally specific end-of-life CST among Chinese oncology nurses? Participants will receive an 8-week communication skills training. Researchers will compare the intervention group and the wait-list group to see if skills, self-efficacy, and outcome expectancy beliefs will be improved.

Read the detailed description

Objectives: The study aims to evaluate the effectiveness of culturally specific end-of-life CST among Chinese oncology nurses.

Design and participants: It is designed as a single-blind, pre-post randomized controlled trial (RCT). Registered nurses who work with advanced cancer patients in hospital settings will be recruited. The participants will be randomly assigned to either the intervention group (IG) or the control group (CG). The IG will receive the end-of-life CST between the two measurement points, and the CG will be a waitlist group and receive the training after the end of data collection.

Data analysis: Demographic information about the participants will be summarised in descriptive statistics. Independent t-tests and chi-square tests are used to investigate the comparability of groups in terms of the demographics generated by randomization. The primary and secondary outcome variables will be examined using covariate-adjusted linear mixed models. This approach enables the consideration of missing data. For non-repeated continuous measurements, ordinary linear regression and logistic models will be adopted. The intention-to-treat (ITT) analysis and post hoc analyses of contaminated data will be performed.

Expected results: Nurses' skills, self-efficacy, and outcome expectancy beliefs will improve after the CST.

02

Conditions studied

  • End-Of-Life

Browse trials for

Keywords

  • Communication
  • Nurse
  • Terminally ill
03

In context

Death

572 studies on the registry are indexed under Death; 111 are open to participants now.

This study's planned enrollment of 148 is above the median of 133 across 260 interventional studies indexed under Death.

Browse Death studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Registered nurses who work with advanced cancer patients in hospital settings
  • Consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Nurses working temporarily in the two hospitals as scholars or trainees from other hospitals
  • Specialized nurses in palliative care
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
148 participants (estimated)

Study arms

  • Experimental
    Intervention group (IG)

    The IG will receive the end-of-life CST between the two measurement points

    Other: The end-of-life communication skills training

  • Other
    Control group (CG)

    The CG will be a waitlist group and receive the training after the end of data collection.

    Other: Routine training activity

Interventions

  • OtherThe end-of-life communication skills training

    Training methods include lectures, video demonstrations, and simulation in small groups (4-5 trainees per group with multidisciplinary roles). Written and audiovisual learning materials will be offered. Each session will be 150 minutes, including lectures and video demonstration (90 min/session) and simulation and feedback (60 min/session). One session will be conducted in two weeks. Totally there will be four sessions completed in 8 weeks.

  • OtherRoutine training activity

    Routine training activities arranged by relevant departments in hospitals

06

What researchers measure

Primary outcomes

  1. Change from Baseline Skills at 3 months

    Measured by Nurses' Clinic Communication Competency Scale, a 58-item self-reported scale which measures six dimensions. A 5-point Likert scale from (1) very poor to (5) very good is used. Higher scores mean a better outcome.

    Time frame: up to 3 months

Secondary outcomes

  1. Change from Baseline Self-efficacy at 3 months

    Measured by Hospice Care Self-efficacy Scale on nurses, a 12 items with a 5-point Likert scale from (1) very diffident to (5) very confident. Higher scores mean a better outcome.

    Time frame: up to 3 months

  2. Change from Baseline Outcome expectancy beliefs 3 months

    Measured by The Communication Outcomes Questionnaire, a 23-item self-report questionnaire with a 9-point Likert scale from 1 = very likely and 9 = very unlikely. Higher scores mean a worse outcome.

    Time frame: up to 3 months

Other outcomes

  1. Acceptance and satisfaction

    Self-developed items and open questions anout the training experience

    Time frame: up to 3 months

07

Study locations

1 of 1 sites recruiting
  • Zhejiang Cancer Hospital
    Hangzhou, Zhejiang 310000, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05888480
Lead sponsor
The Hong Kong Polytechnic University
Responsible party
Dr Joyce Chung (Assistant Professor, School of Nursing, The Hong Kong Polytechnic University) — Principal investigator
First posted
Jun 5, 2023
Start date
Sep 1, 2023
Primary completion
Oct 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Feb 28, 2024

Study contacts

Joyce Chung, PhD
Contact
okjoyce.chung@polyu.edu.hk
852-2766-6322
Joyce Chung, PhD
principal investigator · The Hong Kong Polytechnic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion